Grifols said to be in talks to restructure debt
Grifols (NASDAQ:GRFS) has commenced discussions with banks to refinance its bonds due in 2025, Bloomberg News reported, a day ...
Grifols shares tumble after Brookfield drops takeover plan
Canadian fund Brookfield said on Wednesday it has dropped its plan to take over Spain's Grifols due to a disagreement over ...
Grifols busca refinanciar deuda y línea de crédito, según su CEO
La farmacéutica española Grifols SA está en conversaciones con bancos para refinanciar bonos que vencen el próximo año y ...
Billionaire Grifols Family’s Woes in Focus After Brookfield Exit
For Spain’s billionaire Grifols family, which turned a blood-collection business into one of the world’s largest medical ...
Canadian Fund Drops Bid For Spanish Pharma Firm Grifols
Canadian investment fund Brookfield said Wednesday it has dropped its bid for Spanish pharmaceutical firm Grifols following ...
Grifols: More Attractive Than In A Very Long Time
Grifols rejects Brookfield’s €10.5/share offer, signaling undervaluation. Read why GRFS stock is a strong "Buy" despite the ...
Why Is Spanish Healthcare Grifols Stock Trading Lower On Friday?
Grifols ends acquisition talks with Brookfield over valuation concerns, highlights strong revenue growth and financial ...
Grifols drops as Brookfield is said to drop take-private bid
Grifols (GRFS) stock dropped as Brookfield Asset Management (BAM) is reportedly withdrawing its offer to take the plasma ...
Grifols says ‘not feasible’ for transaction with Brookfield to move forward
In a notice to the Spanish National Securities Market Commission, Grifols (GRFS) stated: “Grifols announces that its Board of Directors held an ...
Grifols Board Announces Termination Of Discussions With Brookfield - Quick Facts
The Board of Directors of Grifols (GRFS) announced the termination of discussions with Brookfield Capital Partners UK regarding a ...
Grifols ADRs Tumble After Brookfield Reportedly Backs Away from Takeover Bid
Grifols' American depositary receipts slumped following a report that Brookfield Asset Management plans to abandon its acquisition of the Spanish pharmaceuticals company. The stock was down 18% at ...